A PHASE 1B STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF A SUPRACHOROIDAL INJECTION OF AVORALSTAT IN PARTICIPANTS WITH DIABETIC MACULAR EDEMA_BCX4161-111
Research Grant
Awarded By
BioCryst Pharmaceuticals, Inc.
Start Date
March 1, 2025
End Date
April 30, 2026
Awarded By
BioCryst Pharmaceuticals, Inc.
Start Date
March 1, 2025
End Date
April 30, 2026